| Amy Curtin, SLP | |
|
645 Baltimore Annapolis Blvd Ste 212, Severna Park, MD 21146-3934 | |
| (410) 544-2500 | |
| Not Available |
| Full Name | Amy Curtin |
|---|---|
| Gender | Female |
| Speciality | Qualified Speech Language Pathologist |
| Experience | 10 Years |
| Location | 645 Baltimore Annapolis Blvd Ste 212, Severna Park, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073961975 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 07915 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cypress Creek Therapy Associates Llc | 4183536410 | 13 |
News Archive
The Institute for Quality and Efficiency in Health Care (IQWiG)investigated in a dossier assessment whether propranolol offers an added benefit in comparison with the appropriate comparator therapy in infants with proliferating infantile haemangioma (sometimes called "strawberry mark").
A protein associated with cancer progression when abundant inside of tumors also unexpectedly regulates the creation of new blood vessels that feed the tumor outside, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the August edition of Cancer Cell.
Astra Tech, a market leader and innovator in the field of implant dentistry and CAD/CAM abutments, announces a global strategic alliance with 3Shape A/S, the Danish-based provider of 3D scanners and CAD/CAM software solutions.
New research from University Hospitals (UH) Case Medical Center Seidman Cancer Center and Case Comprehensive Cancer Center at Case Western Reserve University examined how changes in the genetic composition of breast cancer tumors after brief exposure to either biologic therapy or chemotherapy can predict future clinical outcomes in patients.
Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced that the US Food and Drug Administration (FDA) has approved its first two New Drug Applications (NDAs) based on its proprietary OralXR+(TM) platform technology including the first-ever 24 hour liquid sustained release product.
› Verified 6 days ago
| Provider Name | Cypress Creek Therapy Associates Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1487603064 PECOS PAC ID: 4183536410 Enrollment ID: O20031104000453 |
News Archive
The Institute for Quality and Efficiency in Health Care (IQWiG)investigated in a dossier assessment whether propranolol offers an added benefit in comparison with the appropriate comparator therapy in infants with proliferating infantile haemangioma (sometimes called "strawberry mark").
A protein associated with cancer progression when abundant inside of tumors also unexpectedly regulates the creation of new blood vessels that feed the tumor outside, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the August edition of Cancer Cell.
Astra Tech, a market leader and innovator in the field of implant dentistry and CAD/CAM abutments, announces a global strategic alliance with 3Shape A/S, the Danish-based provider of 3D scanners and CAD/CAM software solutions.
New research from University Hospitals (UH) Case Medical Center Seidman Cancer Center and Case Comprehensive Cancer Center at Case Western Reserve University examined how changes in the genetic composition of breast cancer tumors after brief exposure to either biologic therapy or chemotherapy can predict future clinical outcomes in patients.
Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced that the US Food and Drug Administration (FDA) has approved its first two New Drug Applications (NDAs) based on its proprietary OralXR+(TM) platform technology including the first-ever 24 hour liquid sustained release product.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Curtin, SLP 645 Baltimore Annapolis Blvd Ste 212, Severna Park, MD 21146-3934 Ph: (410) 544-2500 | Amy Curtin, SLP 645 Baltimore Annapolis Blvd Ste 212, Severna Park, MD 21146-3934 Ph: (410) 544-2500 |
News Archive
The Institute for Quality and Efficiency in Health Care (IQWiG)investigated in a dossier assessment whether propranolol offers an added benefit in comparison with the appropriate comparator therapy in infants with proliferating infantile haemangioma (sometimes called "strawberry mark").
A protein associated with cancer progression when abundant inside of tumors also unexpectedly regulates the creation of new blood vessels that feed the tumor outside, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the August edition of Cancer Cell.
Astra Tech, a market leader and innovator in the field of implant dentistry and CAD/CAM abutments, announces a global strategic alliance with 3Shape A/S, the Danish-based provider of 3D scanners and CAD/CAM software solutions.
New research from University Hospitals (UH) Case Medical Center Seidman Cancer Center and Case Comprehensive Cancer Center at Case Western Reserve University examined how changes in the genetic composition of breast cancer tumors after brief exposure to either biologic therapy or chemotherapy can predict future clinical outcomes in patients.
Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced that the US Food and Drug Administration (FDA) has approved its first two New Drug Applications (NDAs) based on its proprietary OralXR+(TM) platform technology including the first-ever 24 hour liquid sustained release product.
› Verified 6 days ago
Miss Kaitlyn Ashley Sikkema, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 645 Baltimore Annapolis Blvd, Ste 111, Severna Park, MD 21146 Phone: 410-544-2500 Fax: 410-384-9703 | |
Mrs. Nancy Beasley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 645 Baltimore Annapolis Blvd, Ste 111, Severna Park, MD 21146 Phone: 410-544-2500 | |
Lisa J Remer, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24 Truck House Rd, Severna Park, MD 21146 Phone: 410-544-4220 Fax: 410-647-9484 | |
Francis Nochera Iv, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 Baltimore Annapolis Blvd, Severna Park, MD 21146 Phone: 410-647-1503 | |
Mrs. Kara Lynn Rice, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 645 Baltimore Annapolis Blvd, 111, Severna Park, MD 21146 Phone: 410-544-2500 Fax: 410-384-9703 | |
Christina T Whitlock, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 645 Baltimore Annapolis Blvd Ste 111, Severna Park, MD 21146 Phone: 410-544-2500 |